CN103494203A - Healthcare food with immunity boosting function - Google Patents
Healthcare food with immunity boosting function Download PDFInfo
- Publication number
- CN103494203A CN103494203A CN201310489806.7A CN201310489806A CN103494203A CN 103494203 A CN103494203 A CN 103494203A CN 201310489806 A CN201310489806 A CN 201310489806A CN 103494203 A CN103494203 A CN 103494203A
- Authority
- CN
- China
- Prior art keywords
- parts
- immunity
- extracts
- weight
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000036039 immunity Effects 0.000 title claims abstract description 28
- 235000013305 food Nutrition 0.000 title abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 30
- 210000000582 semen Anatomy 0.000 claims abstract description 27
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 26
- 235000020691 dandelion extract Nutrition 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 13
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940046009 vitamin E Drugs 0.000 claims abstract description 13
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 13
- 239000011709 vitamin E Substances 0.000 claims abstract description 13
- 244000268590 Euryale ferox Species 0.000 claims abstract description 10
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 10
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 9
- 239000011669 selenium Substances 0.000 claims abstract description 9
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 8
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 8
- 235000013402 health food Nutrition 0.000 claims description 35
- 241000206575 Chondrus crispus Species 0.000 claims description 22
- 150000003346 selenoethers Chemical class 0.000 claims description 22
- 239000002775 capsule Substances 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- 229940067866 dandelion extract Drugs 0.000 claims description 7
- 239000001845 taraxacum officinale leaf extract Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 230000006870 function Effects 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 18
- 210000000952 spleen Anatomy 0.000 abstract description 13
- 230000037396 body weight Effects 0.000 abstract description 9
- 210000000056 organ Anatomy 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000004727 humoral immunity Effects 0.000 abstract description 7
- 238000011161 development Methods 0.000 abstract description 5
- 241000699670 Mus sp. Species 0.000 abstract description 4
- 230000001965 increasing effect Effects 0.000 abstract description 4
- 210000001541 thymus gland Anatomy 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 230000024932 T cell mediated immunity Effects 0.000 abstract 2
- 229940113118 carrageenan Drugs 0.000 abstract 1
- 235000010418 carrageenan Nutrition 0.000 abstract 1
- 229920001525 carrageenan Polymers 0.000 abstract 1
- 239000000679 carrageenan Substances 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- 229940068517 fruit extracts Drugs 0.000 abstract 1
- 230000008621 organismal health Effects 0.000 abstract 1
- 230000002787 reinforcement Effects 0.000 abstract 1
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 46
- 210000004027 cell Anatomy 0.000 description 19
- 230000002708 enhancing effect Effects 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 12
- 230000036541 health Effects 0.000 description 12
- 230000000242 pagocytic effect Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 210000004698 lymphocyte Anatomy 0.000 description 8
- 230000007969 cellular immunity Effects 0.000 description 7
- 241000287828 Gallus gallus Species 0.000 description 6
- 108010006464 Hemolysin Proteins Proteins 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 239000003228 hemolysin Substances 0.000 description 6
- 210000002540 macrophage Anatomy 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 208000026935 allergic disease Diseases 0.000 description 5
- 230000007815 allergy Effects 0.000 description 5
- 230000003111 delayed effect Effects 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 210000003024 peritoneal macrophage Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000035931 haemagglutination Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 239000000976 ink Substances 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000004988 splenocyte Anatomy 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010013183 Dislocation of vertebra Diseases 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 210000001163 endosome Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000000527 lymphocytic effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 101000981253 Mus musculus GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000021179 potluck Nutrition 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000030118 somatic embryogenesis Effects 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of healthcare food, in particular to a healthcare food with an immunity boosting function. The healthcare food is prepared by, by weight, 1-10 parts of selenium carrageenan, 50-150 parts of semen coicis extracts, 100-200 parts of dandelion extracts, 10-100 parts of vitamin E, 1-40 parts of Gorgon fruit extracts and 50-150 parts of barley green. With no evident effect on body weight and weight of immune organs of spleen and thymus gland, the healthcare food has a function of directly reinforcing cell-mediated immunity and humoral immunity rather than realizing immunity reinforcement by increasing weight of mice, and size and weight of the immunity organs, and is few in varieties of raw materials and simple in preparation. Besides, the healthcare food can reinforce immunity of the organisms by dual functions of improving cell-mediated immunity and humoral immunity of the organisms, and has a very important function in ensuring organism health and preventing diseases and disease development.
Description
technical field
The present invention relates to the health food technology field, particularly a kind of health food with enhancing immunity function.
background technology
Immune system is body antagonism exotic disease pathogenic microorganism; defence system as the invasion and attack of the infections sources such as bacterium, virus. the complex networks system that it is comprised of leucocyte, lymphocyte, macrophage, NK cell, Dc cell and antibody forming system etc.; when body is impaired; it can protect body to avoid the pathogenic microorganism invasion and attack such as alien bacteria, virus; the cancer cell formed due to gene mutation in the time of also can identifying with the scavenger Somatic Embryogenesis is heard, and in maintaining body health, prophylactic generation and development, has very important significance.
The health that shows as of hypoimmunity is easy to infected or cancer stricken; Immunity is extraordinary also can produce insalubrious result, as caused allergic reaction, autoimmune disease etc.Because of often ill, increased the weight of the consumption of body, thus generally have a delicate constitution, the performances such as malnutrition, listlessness, fatigue and weak, appetite reduction, sleep-disorder, sick, have an injection and take medicine the normal potluck that just gets married.Each sickly all will could recover for a long time, and usually outbreak repeatedly.If things go on like this can cause health and intelligence development bad, also easily bring out major disease.
Underlying causes is that hypoimmunity or immunity are unsound.When the immune function of human body imbalance, when perhaps immune system is unsound, following point will show effect repeatedly:--flu outbreak repeatedly, tonsillitis shows effect repeatedly, asthma is shown effect repeatedly, bronchitis is shown effect repeatedly, pneumonia is shown effect repeatedly, suffer from diarrhoea and repeatedly show effect etc. you, so necessarily can't neglect.
For thousands of years, traditional Chinese medicine is being prevented and cured diseases, the aspect such as improve the health plays an important role, a large amount of clinical practices confirm, the traditional Chinese medical science is for most of medicine of " strengthening the body resistance to consolidate the constitution ", as ginseng, Chinese caterpillar fungus, pilose antler etc. " help " class medicine, by modern research method, confirm, its Main Function brings into play by strengthening immunity of organisms and resistance the effect of preventing and curing diseases. between nutraceutical and immune system, close relationship is arranged, the mankind's feed directly affects immune normal operation, show after deliberation, body can strengthen by the fill-in that absorbs nourishment the immunocompetence of cell, guarantee the immune normal functions such as tissue and organ, thereby improve the immunity of human body.
And can effectively improve on the market food or the health medicine of immunity function, and effect is not very desirable, some also has side effect to health.
summary of the invention
For the food or the health medicine that solve above raising immunity function, effect is undesirable, health is had to the problem of side effect, the invention provides a kind of effective, have no side effect there is the health food that strengthens immunity function.
The present invention is achieved by the following measures:
A kind of health food with enhancing immunity function, the raw material weight proportioning is as follows:
Selenide of carragheen 1-10 part, Semen Coicis extract 50-150 part, dandelion extract 100-200 part, vitamin E 10-100 part;
Wherein in selenide of carragheen, the weight content of selenium is 2%;
In vitamin E, active principle content is 50%.
Described health food, the raw material weight proportioning is as follows:
1.2 parts of selenide of carragheen, 100 parts of Semen Coicis extracts, 150 parts of dandelion extracts, 50 parts of vitamin Es.
A kind of health food with enhancing immunity function, the raw material weight proportioning is as follows:
Selenide of carragheen 1-10 part, Semen Coicis extract 50-150 part, dandelion extract 100-200 part, vitamin E 10-100 part, Semen euryales extract 1-40 part, Barley Greeg 50-150 part;
Wherein in selenide of carragheen, the weight content of selenium is 2%;
In vitamin E, active principle content is 50%.
Above-mentioned Semen Coicis extract, dandelion extract, Semen euryales extract are water extract.
Described health food, the raw material weight proportioning is as follows:
1.2 parts of selenide of carragheen, 100 parts of Semen Coicis extracts, 150 parts of dandelion extracts, 50 parts of vitamin Es, 20 parts of Semen euryales extracts, 80 parts of Barley Greegs.
Described health food, make capsule, tablet or granule.
Beneficial effect of the present invention:
Health food of the present invention is to body weight, spleen, thymus gland immune organ weight are without obvious impact, this shows that health food of the present invention has the effect of direct enhancing cellular immunity and humoral immunity, rather than the volume and weight of the body weight by increasing mouse, immune organ is realized; Raw material type is few, the preparation method is simple; Health food of the present invention can strengthen immunity of organisms by the double action that improves Cellular Immunity and humoral immunity, for guaranteeing that body health, the generation that prevents disease and development have very important effect.
The specific embodiment
For a better understanding of the present invention, below in conjunction with specific embodiment, further illustrate.
embodiment 1:
A kind of health food with enhancing immunity function, the raw material weight proportioning is as follows:
1 part of selenide of carragheen, 150 parts of Semen Coicis extracts, 100 parts of dandelion extracts, 100 parts of vitamin Es;
Wherein in selenide of carragheen, the weight content of selenium is 2%;
In vitamin E, active principle content is 50%.
Make capsule, tablet or granule.
embodiment 2:
A kind of health food with enhancing immunity function, the raw material weight proportioning is as follows:
10 parts of selenide of carragheen, 50 parts of Semen Coicis extracts, 200 parts of dandelion extracts, 10 parts of vitamin Es;
Wherein in selenide of carragheen, the weight content of selenium is 2%;
In vitamin E, active principle content is 50%.
Make capsule, tablet or granule.
embodiment 3:
A kind of health food with enhancing immunity function, the raw material weight proportioning is as follows:
1.2 parts of selenide of carragheen, 100 parts of Semen Coicis extracts, 150 parts of dandelion extracts, 50 parts of vitamin Es.
Make capsule, tablet or granule.
embodiment 4:
A kind of health food with enhancing immunity function, the raw material weight proportioning is as follows:
1.2 parts of selenide of carragheen, 100 parts of Semen Coicis extracts, 150 parts of dandelion extracts, 50 parts of vitamin Es, 20 parts of Semen euryales extracts, 80 parts of Barley Greegs.
Make capsule, tablet or granule.
embodiment 5:
A kind of health food with enhancing immunity function, the raw material weight proportioning is as follows:
1 part of selenide of carragheen, 150 parts of Semen Coicis extracts, 100 parts of dandelion extracts, 100 parts of vitamin Es, 1 part of Semen euryales extract, 150 parts of Barley Greegs;
Wherein in selenide of carragheen, the weight content of selenium is 2%;
In vitamin E, active principle content is 50%.
Make capsule, tablet or granule.
embodiment 6:
A kind of health food with enhancing immunity function, the raw material weight proportioning is as follows:
10 parts of selenide of carragheen, 50 parts of Semen Coicis extracts, 200 parts of dandelion extracts, 10 parts of vitamin Es, 40 parts of Semen euryales extracts, 50 parts of Barley Greegs;
Wherein in selenide of carragheen, the weight content of selenium is 2%;
In vitamin E, active principle content is 50%.
Make capsule, tablet or granule.
the compliance test result experiment
1 materials and methods
1.1 sample
The capsule that embodiment 1-4 prepares, the 0.4g/ grain.
1.2 animal used as test grouping and tested material give mode
200 of the healthy Kunming mouses of clean level, body weight is 18～22g, Shandong University's Experimental Animal Center provides.
Get each 4.00g of capsule 's content that embodiment 1-4 prepares, respectively with soybean oil to 100mL, mix, wiring solution-forming, give respectively the animal subject gavage, 0.2mL/l0g body weight, every day, gavage was 1 time, and 5Od. recommends consumption according to human oral continuously, and animal used as test is divided 5 groups: 1 group of (1) embodiment; (2) embodiment is 2 groups; (3) embodiment is 3 groups; (4) embodiment is 4 groups; (5) control group (feed and raise isopyknic soybean oil).
1.3 experimental technique
1.3.1 the mouse spleen lymphocyte transformation experiment (mtt assay) that ConA induces
When experiment finishes, the aseptic spleen of getting, make cell suspension, and adjusting cell concentration is 3 * 10/mL, by " mtt assay ", detected. and lymphocytic multiplication capacity deducts with the OD value that adds the ConA hole OD value that does not add the ConA hole and means.
1.3.2 the mouse delayed allergy (DTH) that dinitrofluorobenzene is induced experiment (ear swelling method)
Before experiment finishes, 5d is by the mouse part skin about 3cm * 3cm scope of losing hair or feathers, evenly smear sensitization with 50 μ L DNFB solution, after 5d, l0 μ L DNFB evenly being applied in to the mouse right ear two sides is attacked, after 24h, mouse is put to death in the cervical vertebra dislocation, cut the left and right auricular concha, with card punch take off the 8mm diameter auricle, weigh, mean the degree of DTH with the difference of left and right ear weight.
1.3.3 antibody-producting cell detects (Jerne improves slide method)
Get the sheep blood of defiber, be made into 2% cell suspension, every mouse lumbar injection 0.2mL. puts to death the mouse of 5d after immunity, the aseptic spleen of getting, make cell suspension, 200 eye mesh screens filter, and cell are suspended in 5mL Hank ' s liquid after washing 2 times. by " improvement slide method ", detected, counting hemolysis plaque number, mean the antibody-producting cell number with plaque number/full splenocyte.
1.3.4 the mensuration of serum hemolysin (Hemagglutination Method)
Get the sheep blood of defiber, with physiological saline washing 3 times, be made into the cell suspension of 2% (v/v), O.2mL, after immune 5d, eye socket is got blood to every mouse lumbar injection, by standard " Hemagglutination Method ", is detected, and observes the hemagglutination degree. be calculated as follows the antibody product:
Antibody product=(s
l+ 2s
2+ 3s
3ns
n)
L, 2,3 in formula ... the index that n is the two-fold dilution, the rank that S is the aggegation degree.
1.3.5 mouse carbon is cleaned up experiment
Through the tail vein to injected in mice the india ink with 4 times of normal saline dilutions, every 10g body weight injection 0.1mL, timing immediately after prepared Chinese ink injects, after injecting prepared Chinese ink the 2nd, 1Omin, adjoin veniplex from intraocular respectively and get blood 2O μ L, joins 2mL0.1% Na
2c0
3solution, shake up. with Na
2c0
3solution is made blank, uses semi-automatic biochemical analyzer with 600nm wavelength photometry density value (OD).Mouse is put to death, get liver, spleen, dirty, weigh, be calculated as follows phagocytic index a.
K=(1gOD in formula
1-lg0D
2) (t
2-t
1)
1.3.6 Turnover of Mouse Peritoneal Macrophages is engulfed chicken red blood cell experiment (half endosome method)
To mouse peritoneal injection 2O% (v/v), with giving birth to the hematocrit chicken erythrocyte suspension that buries the salt solution preparation, every mouse lmL, interval 3min, mouse is put to death in the cervical vertebra dislocation, by " half endosome method ", is detected, and with following formula, calculates phagocytic rate and phagocytic index:
1.3.7 NK cytoactive detection (LDH determination method)
The dislocation of mouse cervical vertebra is put to death, and the aseptic spleen of getting, make splenocyte suspension, and adjusting cell concentration is 2 * 10
7/ mL, this is the effector cell. get well-grown YAC-1 cell, adjusting cell concentration is 4 * 10
5/ mL is as target cell. and detected by " LDH determination method ", with following formula, calculated the N cytoactive:
1.4 result is judged
Aspect cellular immune function, humoral immune function, monokaryon one macrophage function, NK cytoactive four, any two aspects positive as a result, can judge that this given the test agent has the enhancing immunity.
1.5 statistical procedures
Application SPSS statistical software carries out the variance analysis statistical disposition.
2 results
2.1 the impact on the mouse cell immunity
2.1.1 the impact on the mouse spleen lymphocyte conversion capability
The lymphocyte transformation ability of each embodiment group mouse is all higher than control group, and the difference of each embodiment group and control group all has statistical significance (in Table 1).
The impact (x ± s) of table 1 on the mouse spleen lymphocyte conversion capability
| Group | n | Lymphocyte transformation ability (OD value) |
| 1 group of embodiment | 10 | 0.2053±0.1143 * |
| 2 groups of embodiment | 10 | 0.2397±0.0574 ** |
| 3 groups of embodiment | 10 | 0.2805±0.0952 ** |
| 4 groups of embodiment | 10 | 0.3123±0.0846 ** |
| Control group | 10 | 0.1025±0.0472 |
With control group, compare,
*p<0.05,
*p<0.01.
2.1.2 the impact on mouse delayed allergy (DTH)
The left and right auricle weight difference of each embodiment group mouse is all higher than control group, and has statistical significance (P<0.05) with the difference of control group, in Table 2.
The impact (x ± s) of table 2 on mouse delayed allergy (DTH)
| Group | n | Left and right auricle weight difference (mg) |
| 1 group of embodiment | 10 | 9.08±2.08 |
| 2 groups of embodiment | 10 | 9.84±2.23 |
| 3 groups of embodiment | 10 | 10.96±0.54 * |
| 4 groups of embodiment | 10 | 12.13±0.38 * |
| Control group | 10 | 7.11±2.42 |
With control group, compare,
*p<0.05.
2.2 the impact on mouse humoral immune
2.2.1 the impact on the antibody-producting cell number of mouse
The antibody-producting cell number of each embodiment group mouse is all higher than control group, and the difference of each embodiment group and negative control group all has statistical significance (in Table 3).
The impact (x ± s) of table 3 on the antibody-producting cell number of mouse
| Group | n | Hemolysis plaque number (1*10/10 6) splenocyte |
| 1 group of embodiment | 10 | 171.25±21.53 * |
| 2 groups of embodiment | 10 | 172.74±20.42 ** |
| 3 groups of embodiment | 10 | 178.18±23.85 ** |
| 4 groups of embodiment | 10 | 185.24±21.36 ** |
| Control group | 10 | 145.84±15.15 |
With control group, compare,
*p<0.05,
*p<0.01.
2.2.2 the impact on the mice serum hemolysin
The antibody product of each embodiment group mouse is all higher than control group, and has statistical significance (P<0.05) with the difference of negative control group, in Table 4.
The impact (x ± s) of table 4 on the mice serum hemolysin
| Group | n | The antibody product |
| 1 group of embodiment | 10 | 155.6±17.7 |
| 2 groups of embodiment | 10 | 158.9±14.1 |
| 3 groups of embodiment | 10 | 167.4±24.2 * |
| 4 groups of embodiment | 10 | 178.2±20.5 * |
| Control group | 10 | 148.4±22.2 |
With control group, compare,
*p<0.05.
2.3 the impact on the monocytes/macrophages phagocytic function of mouse
2.3.1 the impact that the monocytes/macrophages carbon of mouse is cleaned up
The phagocytic index a of each embodiment group mouse is all higher than control group, but the equal not statistically significant of difference of each embodiment group and control group (P > 0.05), in Table 5.
The impact (x ± s) that table 5 is cleaned up the monocytes/macrophages carbon of mouse
| Group | n | Phagocytic index α |
| 1 group of embodiment | 10 | 6.142±0.848 |
| 2 groups of embodiment | 10 | 6.450±0.902 |
| 3 groups of embodiment | 10 | 6.507±1.084 |
| 4 groups of embodiment | 10 | 6.847±1.018 |
| Control group | 10 | 5.664±0.799 |
2.3.2 the peritoneal macrophage of mouse is engulfed to the impact of chicken red blood cell ability
The peritoneal macrophage of each embodiment group mouse is to the phagocytic rate of chicken red blood cell and phagocytic index all higher than control group, but the equal not statistically significant of difference of each embodiment group and control group (P > 0.05), in Table 6.
Table 6 is engulfed the impact (x ± s) of chicken red blood cell ability on the peritoneal macrophage of mouse
| Group | n | Phagocytic rate (%) | The phagocytic rate data transaction | Phagocytic index b |
| 1 group of embodiment | 10 | 18.04±4.35 | 0.435±0.054 | 0.225±0.064 |
| 2 groups of embodiment | 10 | 18.36±4.04 | 0.442±0.058 | 0.225±0.056 |
| 3 groups of embodiment | 10 | 19.01±4.17 | 0.458±0.049 | 0.233±0.058 |
| 4 groups of embodiment | 10 | 19.54±4.33 | 0.472±0.056 | 0.259±0.042 |
| Control group | 10 | 17.11±3.46 | 0.421±0.050 | 0.196±0.048 |
2.4 the impact on the NK cytoactive of mouse
The NK cytoactive of each embodiment group mouse is all higher than control group, and 2,3,4 groups of embodiment wherein have statistical significance with the difference of control group, in Table 7.
The impact (x ± s) of table 7 on the NK cytoactive of mouse
| Group | n | NK cytoactive (%) | NK cytoactive data transaction |
| 1 group of embodiment | 10 | 34.42±4.75 | 0.620±0.051 |
| 2 groups of embodiment | 10 | 43.44±8.83 | 0.706±0.082 * |
| 3 groups of embodiment | 10 | 45.32±7.82 | 0.733±0.084 ** |
| 4 groups of embodiment | 10 | 47.23±7.64 | 0.787±0.063 ** |
| Control group | 10 | 32.05±5.78 | 0.593±0.052 |
With control group, compare,
*p<0.05,
*p<0.01.
3 discuss
Detect health food of the present invention by mouse spleen lymphocyte transformation experiment and delayed allergy experiment and there is the effect that strengthens specific cellular immunity, health products prepared by embodiment 1-4 all can cause the raising of mouse spleen lymphocyte conversion capability, by causing that lymphocytic conversion capability strengthens, cause delayed allergy. clean up experiment by mouse carbon, peritoneal macrophage engulfs the chicken red blood cell experiment and the NK cytoactive detection detects health food of the present invention to the non-specific cell immunization, result shows that health food of the present invention is little on the impact of monokaryon one macrophage phagocytic function of mouse, but can improve the activity of NK cell, binding specificity cellular immunity detects.
In this research, we also measure by serum hemolysin and the antibody-producting cell number is measured the impact of detection health food of the present invention on humoral immunity, result shows, health food of the present invention can cause that the antibody-producting cell number of mouse increases, but serum hemolysin does not have significant change, embodiment 2, the degree that 3 health food antibody-producting cell numbers increase is obvious, and can cause that serum hemolysin improves. in test, our weighing the body weight of mouse, spleen, the thymus gland immune organ weight, detect the impact of health food of the present invention on Mouse Weight and immune organ weight, result shows that health food of the present invention is to body weight, spleen, the thymus gland immune organ weight is without obvious impact, this shows that health food of the present invention has the effect of direct enhancing cellular immunity and humoral immunity, rather than by increasing the body weight of mouse, the volume and weight of immune organ is realized.
In sum, health food of the present invention can strengthen immunity of organisms by the double action that improves Cellular Immunity and humoral immunity, for guaranteeing that body health, the generation that prevents disease and development have very important effect.Therefore, it being developed to food with health role or medicinal application is with a wide range of applications in clinical.
Claims (7)
1. one kind has the health food that strengthens immunity function, it is characterized in that the raw material weight proportioning is as follows:
Selenide of carragheen 1-10 part, Semen Coicis extract 50-150 part, dandelion extract 100-200 part, vitamin E 10-100 part;
Wherein in selenide of carragheen, the weight content of selenium is 2%;
In vitamin E, active principle content is 50%.
2. health food according to claim 1, is characterized in that Semen Coicis extract and dandelion extract are water extract.
3. health food according to claim 1 and 2 is characterized in that the raw material weight proportioning is as follows:
1.2 parts of selenide of carragheen, 100 parts of Semen Coicis extracts, 150 parts of dandelion extracts, 50 parts of vitamin Es.
4. one kind has the health food that strengthens immunity function, it is characterized in that the raw material weight proportioning is as follows:
Selenide of carragheen 1-10 part, Semen Coicis extract 50-150 part, dandelion extract 100-200 part, vitamin E 10-100 part, Semen euryales extract 1-40 part, Barley Greeg 50-150 part;
Wherein in selenide of carragheen, the weight content of selenium is 2%;
In vitamin E, active principle content is 50%.
5. health food according to claim 4, is characterized in that Semen Coicis extract, dandelion extract, Semen euryales extract are water extract.
6. according to the described health food of claim 4 or 5, it is characterized in that the raw material weight proportioning is as follows:
1.2 parts of selenide of carragheen, 100 parts of Semen Coicis extracts, 150 parts of dandelion extracts, 50 parts of vitamin Es, 20 parts of Semen euryales extracts, 80 parts of Barley Greegs.
7. according to the described health food of any one in claim 1-6, it is characterized in that making capsule, tablet or granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310489806.7A CN103494203B (en) | 2013-10-18 | 2013-10-18 | A kind of health food with develop immunitypty function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310489806.7A CN103494203B (en) | 2013-10-18 | 2013-10-18 | A kind of health food with develop immunitypty function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103494203A true CN103494203A (en) | 2014-01-08 |
| CN103494203B CN103494203B (en) | 2016-01-20 |
Family
ID=49859542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310489806.7A Active CN103494203B (en) | 2013-10-18 | 2013-10-18 | A kind of health food with develop immunitypty function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103494203B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115444909A (en) * | 2022-09-15 | 2022-12-09 | 山东创时代生物工程有限公司 | Composition for improving immunity and preparation method thereof |
| CN116458633A (en) * | 2023-03-18 | 2023-07-21 | 广东省农业科学院蚕业与农产品加工研究所 | Health food for improving immunity and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097560A (en) * | 1993-09-08 | 1995-01-25 | 北京医科大学亿康科技开发总公司 | In, the health of older persons nutrient composite |
| CN1297754A (en) * | 1999-11-26 | 2001-06-06 | 云南金碧制药厂 | Tonic food capable of lowering blood lipoid, resisting senility and regulating immunity |
| CN101524492A (en) * | 2009-04-22 | 2009-09-09 | 完美（中国）日用品有限公司 | Traditional Chinese peroral preparation with immunity-strengthening function and preparation method thereof |
| CN101874627A (en) * | 2010-01-21 | 2010-11-03 | 海南京润珍珠生物技术股份有限公司 | Pearl powder health-care food for enhancing immunity |
| KR20120007275A (en) * | 2010-07-14 | 2012-01-20 | 주식회사 면역과학연구소 | Composition comprising plants extract mixture for immune enhancement |
-
2013
- 2013-10-18 CN CN201310489806.7A patent/CN103494203B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097560A (en) * | 1993-09-08 | 1995-01-25 | 北京医科大学亿康科技开发总公司 | In, the health of older persons nutrient composite |
| CN1297754A (en) * | 1999-11-26 | 2001-06-06 | 云南金碧制药厂 | Tonic food capable of lowering blood lipoid, resisting senility and regulating immunity |
| CN101524492A (en) * | 2009-04-22 | 2009-09-09 | 完美（中国）日用品有限公司 | Traditional Chinese peroral preparation with immunity-strengthening function and preparation method thereof |
| CN101874627A (en) * | 2010-01-21 | 2010-11-03 | 海南京润珍珠生物技术股份有限公司 | Pearl powder health-care food for enhancing immunity |
| KR20120007275A (en) * | 2010-07-14 | 2012-01-20 | 주식회사 면역과학연구소 | Composition comprising plants extract mixture for immune enhancement |
Non-Patent Citations (2)
| Title |
|---|
| 吕咏梅: "《四季营养汤谱》", 31 December 2006, article "苡仁蒲公英汤", pages: 89 * |
| 顾奎琴: "《提高免疫力饮食指导》", 30 September 2008, article "苡仁芡实粥", pages: 102 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115444909A (en) * | 2022-09-15 | 2022-12-09 | 山东创时代生物工程有限公司 | Composition for improving immunity and preparation method thereof |
| CN116458633A (en) * | 2023-03-18 | 2023-07-21 | 广东省农业科学院蚕业与农产品加工研究所 | Health food for improving immunity and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103494203B (en) | 2016-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kaleeswaran et al. | Changes in biochemical, histological and specific immune parameters in Catla catla (Ham.) by Cynodon dactylon (L.) | |
| CN103169079A (en) | Health-care food with anti-fatigue and immunity-enhancing effects, and preparation method thereof | |
| US10820615B2 (en) | Powder formulation having a function of enhancing immunity and method for preparing the same | |
| ES2675942T3 (en) | B-glucan treatment of symptoms of upper respiratory tract infection and psychological well-being | |
| CN103829234A (en) | Health food capable of improving immunity and reducing blood fat and preparation method thereof | |
| US10821149B2 (en) | Composition and the use thereof | |
| CN103005471B (en) | Healthcare capsule for improving skin moisture | |
| Nizami et al. | Strong immunity-a major weapon to fight against Covid-19 | |
| CN106820151A (en) | A kind of bivalve compound health composition, preparation method and application | |
| CN102357105A (en) | Combination with effect of enhancing immunity and application thereof | |
| CN103494203B (en) | A kind of health food with develop immunitypty function | |
| CN107343658A (en) | A kind of antifatigue SOD oyster peptides complex capsule and preparation method thereof | |
| CN103584091B (en) | A kind of guarantor with raising immunity, hypolipemic function builds food and preparation method thereof | |
| KR20070100560A (en) | Functional drink for immune- enhancing and manufacturing method thereof | |
| CN101856370A (en) | Medicine combination capable of regulating immunity | |
| CN103330211B (en) | A kind of composition and method of making the same and application with immunoloregulation function | |
| CN106377541A (en) | Polysaccharide composition and application thereof | |
| CN101862354A (en) | Pharmaceutical composition for adjusting immunity | |
| CN107307423A (en) | Product and preparation method with regulation enhancing body's immunity | |
| CN108057049A (en) | A kind of Chinese medicine composition for enhancing cell viability and preparation method thereof | |
| CN106177014A (en) | A kind of Cordyceps militaris (L.) Link. granule of enhancing immunity and preparation method thereof | |
| CN104055969B (en) | A kind of pharmaceutical composition with antiobesity action | |
| CN105998734A (en) | Officinal dendrobium stem granules and preparation method | |
| CN104382961A (en) | Aike capsule for enhancing immunity and preparation method of Aike capsule | |
| CN109198639A (en) | A kind of composition for immunological enhancement containing the lactobacillus and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 250101 Shandong city of Ji'nan province high tech Zone Shun Road No. 2000 Shun Tai Plaza Building 9, room 0604 Applicant after: Jinan Laolaishou Biological Co., Ltd. Address before: 250101 Shandong city of Ji'nan province high tech Zone Shun Road No. 2000 Shun Tai Plaza Building 9, room 0604 Applicant before: Jinan Laolaishou Biology Co., Ltd. |
|
| COR | Change of bibliographic data | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP02 | Change in the address of a patent holder |
Address after: 250101 Shandong Province Jinan High-tech Zone Xinlu Street 1666 Sanqing Qisheng Square 5 Floor 8 Patentee after: Jinan Laolaishou Biological Co., Ltd. Address before: 250101 Shandong city of Ji'nan province high tech Zone Shun Road No. 2000 Shun Tai Plaza Building 9, room 0604 Patentee before: Jinan Laolaishou Biological Co., Ltd. |
|
| CP02 | Change in the address of a patent holder |